Last reviewed · How we verify
NCT03385174
Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow
NA trial testing Carbon monoxide in Headache Disorders in 15 participants. Completed in 12 March 2018.
1 February 2018
Quick facts
| Lead sponsor | Danish Headache Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 15 |
| Start date | 1 October 2017 |
| Primary completion | 1 February 2018 |
| Estimated completion | 12 March 2018 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Carbon monoxide — full drug profile →
Conditions studied
- Headache Disorders — all drugs for Headache Disorders →
Sponsor
Danish Headache Center — full company profile →
Who can join
Adults 18 to 50, any sex, with Headache Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Studying Carbon monoxide effects on brain vessels in healthy volunteers with magnetic resonance imaging.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Carbon Monoxide: from Poison to Clinical Trials.
Siracusa R, Schaufler A, Calabrese V, Fuller PM, et al · · 2021 · cited 57× · PMID 33781582 · DOI 10.1016/j.tips.2021.02.003
Verify or expand the search:
- PubMed search for NCT03385174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Headache Disorders
Currently open trials in the same condition.
- NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat · NA · recruiting
- NCT07268768 — PERSONOLOGICAL STRUCTURE, COGNITIVE FUNCTIONS AND CENTRAL SENSITIZATION IN HEADACHE · recruiting
- NCT07307508 — Efficacy of Scalp Block in Managing Post Subarachnoid Hemorrhage Headache in Critically Ill Patients. A Single Centre Ra · NA · recruiting
- NCT06894121 — Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment · NA · active not recruiting
- NCT06041997 — Smartphone Use Restriction as Treatment of Primary Headache · NA · recruiting
Other Danish Headache Center trials
Trials by the same sponsor.
- NCT07451769 — Selective Activation of the Adrenomedullin Receptors in Migraine · NA · not yet recruiting
- NCT07342296 — Induction of Migraine Attacks With Aura Using Pituitary Adenylate Cyclase Activating Polypeptide-38 · NA · not yet recruiting
- NCT07059546 — Hypersensitivity to Adrenomedullin in Post-Traumatic Headache · NA · recruiting
- NCT07021859 — Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide · NA · recruiting
- NCT06959004 — Substance P-Induced Migraine Attacks Without Aura · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03385174 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Danish Headache Center
- Last refreshed: 13 March 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03385174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing